Ingersoll Rand (India): Unaudited Financial Results of the Company for the quarter and six months ended September 30, 2026 and…
Ingersoll Rand (India) (INGERRAND) filed a disclosure titled "Unaudited Financial Results of the Company for the quarter and six months ended September 30, 2026 and interim dividend". The company is valued at about ₹12,772 crore.
What happened
Ingersoll Rand (India) (INGERRAND) filed a disclosure with the exchanges on 6 November 2026 at 07:13 PM titled "Unaudited Financial Results of the Company for the quarter and six months ended September 30, 2026 and interim dividend".
From the filing: "We enclose herewith a copy of the said Unaudited Financial Results together with Limited Review Report issued by Deloitte Haskins & Sells, Chartered Accountants, statutory auditors of the Company."
Company snapshot
Ingersoll Rand (India) is a small-cap company, with a market value of about ₹12,772 crore.
The stock last traded at ₹4,045.8, against a 52-week range of ₹3,063.3–₹4,955 (18.4% below the high).
Before this filing the shares had moved −2.6% over the month and −6.0% over three months. Average daily turnover over the last 20 sessions was about ₹4.1 crore.
Promoters held 75.00% at the end of Q1 FY27. Foreign institutions owned 1.28% and domestic institutions 8.97%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 315 | 59 | 18.68 |
| Q2 FY26 | 322 | 60.4 | 19.12 |
| Q3 FY26 | 455 | 71.9 | 22.77 |
| Q4 FY26 | 300 | 64.8 | 20.53 |
| Q1 FY27 | 379 | 70.5 | 22.32 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
Market-wide, 10,840 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 6 November 2026: Board meeting — Financial Results/Dividend.
In the news
Recent coverage elsewhere (links open the original publisher):
- India EV Conclave 2026: Ingersoll Rand on the Technologies Transforming EV Manufacturing
- Ingersoll Rand acquires IVEK to expand life sciences unit By Investing.com
- Ingersoll Rand expands life sciences portfolio with acquisition of Ivek
- Ingersoll Rand 3Q 2026: Revenue $2.06B, Net income $669.9M, EPS $1.73— 10-Q Summary
- Ingersoll Rand buys precision-pump maker IVEK to grow life sciences
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.